Pfizer Inc. (NYSE: PFE) Records a Gain of 42.2% in the Last Six Months

Pfizer Inc. (NYSE: PFE) has gained 42.2% in the past six months. This is because of some of its breakthrough projects, including receiving approval from the Food and Drug Administration (FDA) for its COVID-19 booster. The company also received approval for vaccines for children between 12 to 15. Moreover, Pfizer received Breakthrough Therapy Designation (“BTD”) […]

Pfizer Inks A Research Collaboration with Beam Therapeutics

Pfizer (PFE) has inked four-year research collaboration agreement with biotechnology company Beam Therapeutics (BEAM). The two are joining forces to advance the development of novel in-vivo base editing programs. PFE shares rose 0.93% to close at $56.24 on January 10. Pfizer is a company that develops, manufactures, and distributes healthcare products, including medicine and vaccines. […]

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) Are Partnering on a Shingles mRNA Vaccine

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have begun a new partnership to commercialize, develop, and research an mRNA vaccine for Shingles.  The disease, a form of the varicella-zoster virus, affects about 1 in 3 Americans. It affects people with cancer and those above the age of 50. It causes painful, disfiguring patches. […]

Pfizer Inc (NYSE: PFE), Moderna Inc (NASDAQ: MRNA) and Johnson & Johnson (NYSE: JNJ) Booster Jabs For All Who Are 18+, Six Months After Receiving The Second Dose

Pfizer Inc (NYSE: PFE), Moderna Inc (NASDAQ: MRNA) and Johnson & Johnson (NYSE: JNJ) booster dose of the vaccine against coronavirus is administered. Those above 18 can select which booster dose they want Those over 18-years of age can select which of the three dosages they wish to be administered. Pfizer and Moderna booster shot […]

Pfizer Inc. (NYSE: PFE) Releases More Data on Its Oral Drug for COVID-19

Pfizer Inc. (NYSE: PFE) has released additional data from the clinical trial of its oral COVID-19 drug. The company found that Paxlovid, the antiviral, was 89% efficient in protecting high-risk populations from dying or hospitalization due to COVID-19. The total dose consists of three pills taken two times a day for five days. It prevents […]

Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 Vaccine Could Work Against Omicron

Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine can protect against the omicron variant after two doses. This finding results from a study from Africa Health Research Institute, South Africa. The study shows that blood from people who had a previous infection and had taken two doses of the vaccine could protect […]

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) Seek FDA Approval for Boosters for Ages 16-18

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) will seek approval from the Food and Drug Administration (FDA) for a booster shot for teenagers aged 16-18 years. This announcement comes in the heels of Biden offering Americans assurance about the omicron strain of the coronavirus. Countries omicron has affected Experts have spotted the new […]

The Center for Disease Control and Prevention Approves Moderna Inc (NASDAQ: MRNA) and Pfizer Inc. (NYSE: PFE) COVID-19 Boosters

An independent committee that advises the Center for Disease Control and Prevention (CDC) agreed to recommend Moderna Inc (NASDAQ: MRNA) and Pfizer Inc. (NYSE: PFE) COVID-19 boosters for people aged 18 and above. They said that healthcare workers could give the booster six months after the second dose. Dr. Rochelle Walensky made the recommendation official […]

Pfizer Inc. (NYSE: PFE) Develops Antiviral Pill That Could Lower Demand for COVID-19 Vaccines

Pfizer Inc. (NYSE: PFE) announced that it had developed an antivirus pill causing the stocks of vaccine producers in Asia to fall. The antivirus pill known as Pexlovid is 89% effective in decreasing the risk of hospitalization or death from COVID-19 Shares for the Chinese vaccine maker, Cansino Biologics Inc (OTCMKTS: CASBF), dropped by 17% […]

Pfizer Inc (NYSE: PFE) Gets Approval For Children’s COVID-19 Vaccine

Pfizer Inc (NYSE: PFE) has announced that the U.S Food and Drug Administration (FDA) has approved its COVID-19 vaccine for children aged 5-11. The Centre for Disease Control and Prevention’s immunization advisory committee also met to decide how healthcare workers administer the shot and who will receive it. Rochelle Walensky, the director, signed off on […]

Pfizer Inc. (NYSE: PFE) Anticipating Vaccine Approval for Children Above 5, US Government Donates Vaccine to Nigeria

The US White House has informed governors to prepare for vaccination of children from five years from next month in anticipation of approval of Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine for the age group in the coming weeks. Already the Biden administration has bought 65 million pediatric doses of the […]

Moderna Inc.’s (NASDAQ: MRNA) Vaccine Effective Against Delta Variant Than Pfizer Inc.’s (NYSE: PFE), Study Shows

A study by Mayo Clinic has shown that the risk of someone vaccinated with the Moderna Inc. (NASDAQ: MRNA) vaccine getting infected with the delta variant is lower compared to someone who received the Pfizer Inc. (NYSE: PFE) vaccine.  Moderna vaccine offers more protection than Pfizer vaccine  Results of the study awaiting review established that, […]

Israeli Reveals the Pfizer Inc (NYSE: PFE) Covid Vaccine’s Effectiveness as Standing at 39% as the Delta Sting Grows More Severe

Israeli Health Ministry has its reservations about the Pfizer Inc (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX) Covid-19 vaccine. The segment discloses that the vaccine is 39% effective in Israel. The effects of the Delta variant continue to be felt rather strongly in the country, but it is a good thing that the vaccine is helping in […]

The Covid Vaccine Market is a Long Game in the Early Innings (BNTX, AZN, DYAI, NVAX, MRNA, PFE, JNJ)

The Delta variant is surging as case numbers hit new highs in many countries around the world, including the US. One of the dynamics that has recently migrated to the center of the public debate is that surrounding so-called “breakthrough cases” – symptomatic Covid-19 infections among the already vaccinated. While hospitalizations and deaths among this […]